Approvals/TGA/SANDOSTATIN LAR octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack

Approved

STANDARD

SANDOSTATIN LAR octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack

Approval Id: 982bf519d2fa024b
Product Name: SANDOSTATIN LAR octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack
Artg Id: 227963
Artg Name: SANDOSTATIN LAR octreotide (as acetate) 20 mg modified release injection vial plus diluent prefilled syringe composite pack
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2015-03-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-CMI-02831-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01415-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

982bf519d2fa024b

Type

Standard